Indegene announces new Hyderabad center to boost global delivery operations

Indegene Limited, a leading digital-first life sciences commercialization company, has unveiled a new global delivery center in Hyderabad, further cementing its position as a critical partner for the biopharma and medical technology industries. This strategic expansion, announced on 18 November 2024, comes as the pharmaceutical sector faces mounting pressure to innovate and modernize operations amidst intensifying global challenges.

Hyderabad, already renowned as a hub for pharmaceutical and technological talent, has become an essential node in Indegene’s global network. The new center is expected to accelerate the company’s ability to help healthcare organizations become future-ready by leveraging advanced medical expertise and innovative, fit-for-purpose technologies.

In a statement, Manish Gupta, Chairman and CEO of Indegene, noted that the new Hyderabad center reflects the company’s commitment to enabling life sciences companies to modernize commercial, medical, and clinical operations. He emphasized that Indegene’s focus on generative AI (GenAI) and technology-driven solutions positions it as a transformative partner for the global healthcare sector.

Indegene’s reputation as a leader in life sciences digital services has been underscored by accolades such as the Everest Group’s designation as a Leader in its Life Sciences Digital Services Specialist PEAK Matrix® Assessment 2024. Additionally, the company’s innovative strides in GenAI were recognized by HFS Research, further solidifying its leadership in the industry.

With six operational hubs and 18 offices across North America, Europe, and Asia, Indegene serves top biopharma firms, emerging biotech entities, and medical device companies. This extensive network highlights its ability to scale solutions tailored to meet the diverse needs of clients worldwide. The new Hyderabad center will strengthen these capabilities, enhancing service delivery and enabling more agile responses to industry demands.

India continues to rise as a pivotal player in the global pharmaceutical ecosystem, thanks to its vast talent pool and cost-effective technological infrastructure. Companies like Indegene are at the forefront of leveraging this environment, offering transformative solutions that enable their partners to operate in a scalable and technologically advanced manner.

Indegene’s expansion also aligns with its broader mission of creating personalized and omnichannel experiences for healthcare stakeholders, driving efficiency throughout the product lifecycle. The Hyderabad center represents another significant step in this direction, reinforcing the company’s aim to redefine healthcare commercialization.